Claims for Patent: 12,409,156
✉ Email this page to a colleague
Summary for Patent: 12,409,156
| Title: | Stable aqueous hydroxycarbamide solution |
| Abstract: | The present invention provides a stable aqueous hydroxycarbamide solution comprising: hydroxycarbamide; a pH adjuster being sodium hydroxide, potassium hydroxide, sodium bicarbonate, and sodium carbonate, or a mixture of one or more of these substances; and optionally a preservative being a base of methyl hydroxybenzoate and/or ethyl hydroxybenzoate; wherein: the solution is controlled to have a pH of between 6.1 and 7.1. The solution of the present invention is beneficial as compared to solutions according to the prior art in that it can be safely stored at ambient temperatures for prolonged periods of time without significant degradation. |
| Inventor(s): | Khunal Bhavsar, Michael Edge, Claire Hodkinson, Kelly Grant, Hussain Mulla, Peter White |
| Assignee: | Nova Laboratories , NOVA LABORATORIES Ltd |
| Application Number: | US17/055,332 |
| Patent Claims: |
1. A stable aqueous hydroxycarbamide solution comprising: an aqueous solution comprising a hydroxycarbamide, wherein, after the aqueous solution is stored for four weeks at a temperature of 25° C. and 60% RH, the aqueous solution comprises less than 0.5% w/v of carbamoyloxyurea, less than 0.1% w/v of hydroxylamine, and has an initial pH of between 6.5 and 6.7. 2. A stable aqueous hydroxycarbamide solution according to claim 1, further comprising a preservative comprising a methyl hydroxybenzoate or an ethyl hydroxybenzoate. 3. A stable aqueous hydroxycarbamide solution according to claim 1 further comprising a viscosity modifying agent. 4. A stable aqueous hydroxycarbamide solution according to claim 3, wherein the viscosity modifying agent is xanthan gum. 5. A stable aqueous hydroxycarbamide solution according to claim 1, further comprising a sweetener. 6. A stable aqueous hydroxycarbamide solution according to claim 5, wherein the sweetener is sucralose, aspartame, or acesulfame K. 7. A stable aqueous hydroxycarbamide solution according to claim 1, further comprising a flavouring agent. 8. A stable aqueous hydroxycarbamide solution according to claim 1, wherein the hydroxycarbamide content is from 5% w/v to 15% w/v. 9. A stable aqueous hydroxycarbamide solution according to claim 8, wherein the hydroxycarbamide content is from 9% w/v to 11% w/v. 10. A stable aqueous hydroxycarbamide solution according to claim 9, wherein the aqueous solution has a concentration of the hydroxycarbamide of 10% w/v. 11. A stable aqueous hydroxycarbamide solution according to claim 1, wherein the aqueous solution has a pH of 6.6 after the aqueous solution is stored for four weeks at a temperature of 25° C. and 60% RH. 12. A stable aqueous hydroxycarbamide solution according to claim 2, wherein the aqueous solution has a concentration of the preservative of from 0.01% w/v to 0.1% w/v. 13. A stable aqueous hydroxycarbamide solution according to claim 1 comprising: a preservative comprising a methyl hydroxybenzoate and/or an ethyl hydroxybenzoate; a viscosity modifying agent; a sweetener; and a flavouring agent. 14. A stable aqueous hydroxycarbamide solution according to claim 1 for use in the treatment of sickle cell disease. 15. A stable aqueous hydroxycarbamide solution comprising: a hydroxycarbamide; a pH adjuster, wherein the pH adjuster is sodium hydroxide, potassium hydroxide, sodium bicarbonate, sodium carbonate, or a mixture thereof, and wherein the aqueous hydroxycarbamide solution has a pH of between 6.5 and 6.7. 16. A stable aqueous hydroxycarbamide solution according to claim 15, further comprising a preservative comprising a methyl hydroxybenzoate or an ethyl hydroxybenzoate. 17. A stable aqueous hydroxycarbamide solution according to claim 15 for use in the treatment of sickle cell disease. 18. A stable aqueous hydroxycarbamide solution comprising: an aqueous solution comprising a hydroxycarbamide; a preservative, wherein the preservative comprises a methyl hydroxybenzoate or an ethyl hydroxybenzoate, and wherein, after the aqueous solution is stored for four weeks at a temperature of 25° C. and 60% RH, the aqueous solution comprises less than 0.5% w/v of carbamoyloxyurea, less than 0.1% w/v of hydroxylamine, and has a pH of between 6.5 and 6.7. 19. A stable aqueous hydroxycarbamide solution according to claim 18, wherein the aqueous solution has a pH of 6.6 after the aqueous solution is stored for four weeks at a temperature of 25° C. and a relative humidity of 60% RH. 20. A stable aqueous hydroxycarbamide solution comprising: an aqueous solution comprising a hydroxycarbamide, wherein, after the aqueous solution is stored for two years at a temperature of 5° C. and 60% RH, the aqueous solution comprises less than 0.5% w/v of carbamoyloxyurea, less than 0.1% w/v of hydroxylamine, and has an initial pH of between 6.5 and 6.7. |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
